Two studies – one using neuropsychological assessments, another examining performance on standardized testing – show no association between prenatal antipsychotic exposure and neurodevelopmental outcomes.

The post Reassuring Data on Neurodevelopmental Outcomes in Children with Prenatal Exposure to Antipsychotic Medications appeared first on MGH Center for Women’s Mental Health.

Leave a Reply

Your email address will not be published. Required fields are marked *